Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (791-800 of 2,116) with videos related to

Pageof 212
Sort By:
Helicobacter|August 3, 2007
Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditionsSara K Lindén, Kim M Driessen, Michael A McGuckin
Helicobacter|August 3, 2007
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapyHsiu-Chi Cheng, Wei-Lun Chang, Wei-Ying Chen, et al.
Helicobacter|November 16, 2007
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapyJung Mook Kang, Nayoung Kim, Dong Ho Lee, et al.
Helicobacter|November 16, 2007
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rateHyo Sun Choi, Dong Il Park, Sang Jun Hwang, et al.
Helicobacter|January 24, 2007
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritisBruno Annibale, Edith Lahner, Annalisa Santucci, et al.
Helicobacter|January 24, 2007
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in KoreaByeong Gwan Kim, Dong Ho Lee, Byong Duk Ye, et al.
Helicobacter|November 7, 2006
Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsiaY Erzin, V Koksal, S Altun, et al.
Helicobacter|November 7, 2006
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003Michael G Bruce, Dana L Bruden, Brian J McMahon, et al.
Helicobacter|February 5, 2009
Autoimmune angioneurotic edema in a patient with Helicobacter pylori infectionDidier Mukeba, Kavitha Chandrikakumari, Jean-Baptiste Giot, et al.
Helicobacter|February 5, 2009
Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern TaiwanKuei-Hsiang Hung, Bor-Shyang Sheu, Wei-Lun Chang, et al.
Pageof 212

Showing results (791-800 of 2,116) with videos related to

Sort By:
Pageof 212
Helicobacter|August 3, 2007
Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditionsSara K Lindén, Kim M Driessen, Michael A McGuckin
Helicobacter|August 3, 2007
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapyHsiu-Chi Cheng, Wei-Lun Chang, Wei-Ying Chen, et al.
Helicobacter|November 16, 2007
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapyJung Mook Kang, Nayoung Kim, Dong Ho Lee, et al.
Helicobacter|November 16, 2007
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rateHyo Sun Choi, Dong Il Park, Sang Jun Hwang, et al.
Helicobacter|January 24, 2007
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritisBruno Annibale, Edith Lahner, Annalisa Santucci, et al.
Helicobacter|January 24, 2007
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in KoreaByeong Gwan Kim, Dong Ho Lee, Byong Duk Ye, et al.
Helicobacter|November 7, 2006
Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsiaY Erzin, V Koksal, S Altun, et al.
Helicobacter|November 7, 2006
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003Michael G Bruce, Dana L Bruden, Brian J McMahon, et al.
Helicobacter|February 5, 2009
Autoimmune angioneurotic edema in a patient with Helicobacter pylori infectionDidier Mukeba, Kavitha Chandrikakumari, Jean-Baptiste Giot, et al.
Helicobacter|February 5, 2009
Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern TaiwanKuei-Hsiang Hung, Bor-Shyang Sheu, Wei-Lun Chang, et al.
Pageof 212